Top Stories AdvanCell Unveils Key Cancer Therapy Insights at EANM’25 URGENT UPDATE: AdvanCell, a pioneering radiopharmaceutical company, is set to present groundbreaking insights into its Pb-212-based targeted alpha therapies for cancer at the 2025... Editorial29 September, 2025